share_log

424B2: Prospectus

424B2: Prospectus

424B2：募資說明書
美股sec公告 ·  06/15 04:55
牛牛AI助理已提取核心訊息
Bank of America Corporation (BofA) has announced the pricing of its Contingent Income Issuer Callable Yield Notes Linked to the Least Performing of the SPDR S&P Biotech ETF, the SPDR S&P Regional Banking ETF, and the VanEck Gold Miners ETF, due June 17, 2027. The Notes, priced on June 12, 2024, will issue on June 17, 2024, with an approximate 3-year term, unless called prior to maturity. Payments on the Notes are contingent on the performance of the individual ETFs, with a coupon rate of 14.20% per annum payable monthly if certain conditions are met. The Notes are callable monthly beginning December 17, 2024, at BofA's option. If not called, the investment is subject to downside exposure to the least performing ETF, with up to 100% of the principal at risk. All payments are subject to the credit risk of BofA Finance LLC and Bank of America Corporation. The Notes will not be listed on any securities exchange and have an initial estimated value of $982.10 per $1,000.00 in principal amount, which is less than the public offering price.
Bank of America Corporation (BofA) has announced the pricing of its Contingent Income Issuer Callable Yield Notes Linked to the Least Performing of the SPDR S&P Biotech ETF, the SPDR S&P Regional Banking ETF, and the VanEck Gold Miners ETF, due June 17, 2027. The Notes, priced on June 12, 2024, will issue on June 17, 2024, with an approximate 3-year term, unless called prior to maturity. Payments on the Notes are contingent on the performance of the individual ETFs, with a coupon rate of 14.20% per annum payable monthly if certain conditions are met. The Notes are callable monthly beginning December 17, 2024, at BofA's option. If not called, the investment is subject to downside exposure to the least performing ETF, with up to 100% of the principal at risk. All payments are subject to the credit risk of BofA Finance LLC and Bank of America Corporation. The Notes will not be listed on any securities exchange and have an initial estimated value of $982.10 per $1,000.00 in principal amount, which is less than the public offering price.
美國銀行公司（BofA）宣佈定價其可轉換收益發行人可贖回意願債券，聯繫到SPDR S&P生物科技etf, SPDR S&P區域銀行etf, VanEck黃金礦工etf之最差表現，截至2027年6月17日到期。註明，債券發行日期爲2024年6月17日，期限大約3年，除非提前贖回，按月支付的優惠券利率爲14.20%。BofA可選擇月度贖回債券，自2024年12月17日起。如果不贖回，則該投資將面臨最差表現etf的下行風險，最高可達100%的本金風險。所有付款都受美國銀行融資有限責任公司和美國銀行公司的信用風險影響。債券不會在任何證券交易所上市，初始估值爲每1000.00元本金982.10美元，低於公開發行價格。
美國銀行公司（BofA）宣佈定價其可轉換收益發行人可贖回意願債券，聯繫到SPDR S&P生物科技etf, SPDR S&P區域銀行etf, VanEck黃金礦工etf之最差表現，截至2027年6月17日到期。註明，債券發行日期爲2024年6月17日，期限大約3年，除非提前贖回，按月支付的優惠券利率爲14.20%。BofA可選擇月度贖回債券，自2024年12月17日起。如果不贖回，則該投資將面臨最差表現etf的下行風險，最高可達100%的本金風險。所有付款都受美國銀行融資有限責任公司和美國銀行公司的信用風險影響。債券不會在任何證券交易所上市，初始估值爲每1000.00元本金982.10美元，低於公開發行價格。
有用
沒用

該公告為獨立文件：

獨立文件1

獨立文件2

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。